1. Averette, H. E., Lovecchio, J. L., Townsend, P. A., Sevin, B. U., Girtanner, R. E., et al. (1983): Retroperitoneal lymphatic involvement by ovarian carcinoma. In: Cancer Campaign. Carcinoma of the ovary (Grundmann, E., Hrsg.), Vol. 7, S. 101. Stuttgart: Fischer.
2. Bast, R. C., Knapp, R. C. (1984): Immunologic approaches to the management of ovarian carcinoma. Semin. Oncol. 11, 264.
3. Beecham, J. B., Helmkamp, B. F., Rubin, P. (1983): Tumors of the female reproductive organs. In: Clinical Oncology (Rubin, P., Hrsg.), 6. Aufl., S. 428. American Cancer Society.
4. Bergquist, A., Kullander, S., Thorell, J. (1981): A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxyprogesteroneacetate. Acta Obstet. Gynecol. Scand., Suppl. 101, 75.
5. Bitran, J. D., Desser, R. K., Billings, A. A., Kozloff, M. F., Shapiro, C. M. (1982): Acute nephrotoxicity following Cisdichlorodiammine-Platinum. Cancer 49, 1784.